Literature DB >> 22306380

Suitability of the Montreal cognitive assessment versus the mini-mental state examination in detecting vascular cognitive impairment.

Masafumi Ihara1, Yoko Okamoto, Ryosuke Takahashi.   

Abstract

The Mini-Mental State Examination (MMSE) has been criticized as being an insufficient screening test for patients with vascular cognitive impairment because of its insensitivity to visuospatial and executive functional deficits. The Montreal Cognitive Assessment (MoCA) was designed to be more sensitive to such deficits, and thus may be a superior screening instrument for vascular cognitive impairment. Twelve patients with extensive leukoaraiosis detected on magnetic resonance imaging (average age, 76.0 ± 8.7 years) underwent neurologic and cognitive testing, including MMSE and the Japanese version of the MoCA (MoCA-J). Accepted cutoff scores of <27 for the MMSE and <26 for the MoCA-J were taken to indicate cognitive impairment. Z-scores were calculated to evaluate the discriminating ability of individual MMSE and MoCA-J subtest scores. Although there was a strong correlation between the total MMSE and total MoCA-J scores (r = 0.90; P < .0001), MMSE scores were skewed toward the higher end of the range (range, 18-30; median, 28), whereas MoCA-J scores were normally distributed (range, 9-28; median, 21). Of the 7 patients with an unimpaired MMSE score, 6 (86%) had an impaired MoCA-J score. Z-scores were >5 for 4 MMSE subtests (orientation, registration, naming, and language) but for only 1 MoCA-J subtest (naming). The MoCA-J better discriminated cognitive status in subjects with extensive leukoaraiosis. Our findings suggest that the MoCA-J is more sensitive than the MMSE in screening for cognitive impairment in patients with subcortical vascular cognitive impairment.
Copyright © 2013 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Leukoaraiosis; MoCA; dementia; screening; stroke

Mesh:

Year:  2012        PMID: 22306380     DOI: 10.1016/j.jstrokecerebrovasdis.2012.01.001

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  11 in total

1.  The effects of depression, anxiety and sleep disturbances on cognitive impairment in patients with chronic obstructive pulmonary disease.

Authors:  Yesim Güzey Aras; Abdülkadir Tunç; Belma Doğan Güngen; Adil Can Güngen; Yusuf Aydemir; Bekir Enes Demiyürek
Journal:  Cogn Neurodyn       Date:  2017-08-05       Impact factor: 5.082

2.  Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging.

Authors:  David R Roalf; Paul J Moberg; Sharon X Xie; David A Wolk; Stephen T Moelter; Steven E Arnold
Journal:  Alzheimers Dement       Date:  2012-12-21       Impact factor: 21.566

3.  Screening for very mild subcortical vascular dementia patients aged 75 and above using the montreal cognitive assessment and mini-mental state examination in a community: the kurihara project.

Authors:  Mari Kasai; Kenichi Meguro; Kei Nakamura; Masahiro Nakatsuka; Yoshitaka Ouchi; Naofumi Tanaka
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-11-10

4.  Use of the MoCA in Detecting Early Alzheimer's Disease in a Spanish-Speaking Population with Varied Levels of Education.

Authors:  Yan Zhou; Freddy Ortiz; Christopher Nuñez; David Elashoff; Ellen Woo; Liana G Apostolova; Sheldon Wolf; Maria Casado; Nenette Caceres; Hemali Panchal; John M Ringman
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2015-03-06

5.  Detection of cognitive impairment in patients with obstructive sleep apnea hypopnea syndrome using mismatch negativity.

Authors:  Xiaohui Wen; Ningyu Wang; Jinfeng Liu; Zhanfeng Yan; Zhonghai Xin
Journal:  Neural Regen Res       Date:  2012-07-15       Impact factor: 5.135

6.  Does cerebral large-artery disease contribute to cognitive impairment?

Authors:  Satoshi Kimura; Toshiyasu Ogata; Junko Watanabe; Tooru Inoue; Yoshio Tsuboi
Journal:  eNeurologicalSci       Date:  2017-06-13

7.  Diagnostic Values of Serum Levels of Homocysteine and Uric Acid for Predicting Vascular Mild Cognitive Impairment in Patients with Cerebral Small Vessel Disease.

Authors:  Ting Wang; Zhong-Wu Sun; Liang-Qing Shao; Xiao-Bin Xu; Yang Liu; Mao Qin; Xiang Weng; Yong-Xiang Zhang
Journal:  Med Sci Monit       Date:  2017-05-10

8.  Validation of the R2CHADS2 and CHADS2 Scores for Predicting Post-stroke Cognitive Impairment.

Authors:  Kazuo Washida; Hisatomo Kowa; Hirotoshi Hamaguchi; Fumio Kanda; Tatsushi Toda
Journal:  Intern Med       Date:  2017-09-15       Impact factor: 1.271

9.  Synergistic Effects of Aldehyde Dehydrogenase 2 Polymorphisms and Alcohol Consumption on Cognitive Impairment after Ischemic Stroke in Han Chinese.

Authors:  Ying Yu; Jie Gao; Shasha Wang; Heng Lv; Liping Xiao; Hengyuan Shi; Xianjie Jia
Journal:  Behav Neurol       Date:  2021-06-24       Impact factor: 3.342

10.  Agreement and conversion formula between mini-mental state examination and montreal cognitive assessment in an outpatient sample.

Authors:  Luqman Helmi; David Meagher; Edmond O'Mahony; Donagh O'Neill; Owen Mulligan; Sutha Murthy; Geraldine McCarthy; Dimitrios Adamis
Journal:  World J Psychiatry       Date:  2016-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.